Gilead Sciences (GILD) Clarifies Remdesivir Data - RBC Capital
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| Gilead Sciences (NASDAQ: GILD) | Delayed: 174.88 +7.41 (4.42%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $167.47 | 52 Week High | $108.63 | |||
| Open | $171.89 | 52 Week Low | $71.39 | |||
| Day High | $175.25 | P/E | 96.62 | |||
| Day Low | $168.84 | EPS | $1.81 | |||
| Volume | 4,923,256 | |||||
